Spyre Therapeutics Inc. (SYRE)
undefined
undefined%
At close: undefined
24.12
0.12%
After-hours Dec 13, 2024, 04:15 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -338.79M -83.81M -65.80M -80.89M -78.25M -44.35M -27.24M -21.70M
Depreciation & Amortization 744.00K 1.57M 1.58M 996.00K 901.00K 293.00K 249.00K 132.00K
Stock-Based Compensation 25.68M 7.11M 8.04M 6.26M - - - -
Other Working Capital -5.80M -2.86M 768.00K -2.00M 4.52M 3.88M 1.50M 976.00K
Other Non-Cash Items 217.67M 823.00K 90.00K 619.00K 3.78M 1.93M 4.77M 1.07M
Deferred Income Tax - -327.00K 548.00K -213.00K - - - -
Change in Working Capital -5.21M -5.50M 1.83M -2.54M 7.10M 7.20M -198.00K 1.45M
Operating Cash Flow -99.91M -80.14M -53.72M -75.78M -65.69M -32.19M -24.61M -18.84M
Capital Expenditures - -38.00K -573.00K -4.28M -1.49M -422.00K -619.00K -212.00K
Acquisitions 3.04M - - - - - - -
Purchase of Investments -166.80M -39.50M -133.08M -129.00M -91.93M -62.18M -64.11M -20.39M
Sales Maturities Of Investments 39.90M 96.55M 111.03M 125.68M 91.68M 47.37M 42.20M 8.45M
Other Investing Acitivies 15.47M - - - - - - -
Investing Cash Flow -108.39M 57.01M -22.62M -7.60M -1.74M -15.23M -22.53M -12.16M
Debt Repayment -16.00K -418.00K -510.00K -20.00K -25.00K - - -
Common Stock Repurchased - - - - - - - -
Dividend Paid - - - - - - - -
Other Financial Acitivies 191.98M 222.00K 1.90M 816.00K 1.45M 3.02M 833.00K 76.00K
Financial Cash Flow 361.08M 42.68M 1.39M 154.51M 65.72M 57.07M 12.21M 49.37M
Net Cash Flow 152.80M 19.44M -74.96M 71.18M -3.21M 9.64M -34.93M 18.37M
Free Cash Flow -99.91M -80.18M -54.29M -80.06M -67.18M -32.61M -25.23M -19.05M